---
document_datetime: 2025-01-10 17:18:57
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/prehevbri-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: prehevbri-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.5408584
conversion_datetime: 2025-12-24 18:32:22.450846
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
<!-- image -->

| Application number   | Scope                                                                                                                                                                                               | Opinion/ Notification 1 issued on product   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0008              | B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes | 21/12/2023                                  |                                             | SmPC, Labelling and PL           |           |

PreHevbri Procedural steps taken and scientific information after the authorisation Medicinal product no longer authorised

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

| IB/0007   | B.II.f.1.b.5 - Stability of FP - Extension of the shelf life of the finished product - Biological/immunological medicinal product in accordance with an approved stability protocol                                                                                                                   | 06/11/2023   |        | SmPC            |              |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------|-----------------|--------------|
| II/0006   | B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological substance which may have a significant impact on the medicinal product and is not related to a protocol                                            | 12/10/2023   | n/a    |                 |              |
| IA/0005   | B.II.c.1.a - Change in the specification parameters and/or limits of an excipient - Tightening of specification limits                                                                                                                                                                                | 13/04/2023   | n/a    | longer          |              |
| IB/0004   | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                  | 12/04/2023   | n/a no |                 |              |
| IAIN/0003 | A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release product                                                                                                                                                                    | 17/03/2023   |        | Annex II and PL |              |
| IA/0002/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure Change in the specification parameters Medicinal | 14/12/2022   | n/a    |                 | B.II.c.1.c - |

<div style=\"page-break-after: always\"></div>

<!-- image -->